XML 115 R101.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Details of Consideration Transferred (Details) - USD ($)
Sep. 12, 2023
May 02, 2022
Dec. 31, 2021
Apr. 14, 2021
Jan. 05, 2021
OmicEra          
Acquisition          
Common stock issued   $ 14,792,000      
Contingent consideration   4,600,000      
Cash paid related to working capital adjustment   16,000      
Total purchase price   $ 19,408,000      
PreventionGenetics          
Acquisition          
Common stock issued     $ 84,252,000    
Cash     101,129,000    
Total purchase price     $ 185,381,000    
Ashion Analytics          
Acquisition          
Common stock issued       $ 16,224,000  
Contingent consideration       19,000,000  
Cash       74,775,000  
Total purchase price       $ 109,999,000  
Thrive          
Acquisition          
Common stock issued         $ 1,175,431,000
Contingent consideration         331,348,000
Cash         584,996,000
Total purchase price         2,187,054,000
Fair value of replaced equity awards         52,245,000
Previously held equity investment fair value         $ 43,034,000
Resolution Bioscience          
Acquisition          
Common stock issued $ 1,675,000        
Cash 52,527,000        
Total purchase price $ 54,202,000